Surveillance IDs New Tumors in Children With Cancer Predisposition

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 21, 2024 -- Standardized surveillance identifies new tumors among children with a wide spectrum of cancer predisposition syndromes (CPSs), according to a study published online June 20 in JAMA Oncology.

Alise Blake, from St. Jude Children's Research Hospital in Memphis, Tennessee, and colleagues reviewed surveillance outcomes for children and young adults from birth to age 23 years with a clinical and/or molecular CPS diagnosis. A total of 274 children and young adults with 35 CPSs were monitored using standard surveillance regimens for their CPS at a specialty pediatric oncology center.

The researchers found that 35 asymptomatic tumors were detected in 27 patients (9.9 percent of the cohort) through surveillance during the study period and five symptomatic tumors were detected in five patients (1.8 percent of the cohort) outside surveillance, two of whom also had tumors detected through surveillance. Of the 35 tumors, 10 (28.6 percent) were identified on first surveillance imaging. Malignant solid and brain tumors identified through surveillance were more often localized than similar tumors detected before diagnosis of CPS (20 of 24 versus 71 of 125 [83.3 versus 56.8 percent]). Completely negative margins were obtained in 17 of the 24 tumors identified through surveillance and surgically resected. High sensitivity, specificity, positive predictive value, and negative predictive value were seen across imaging modalities (96.4, 99.6, 94.3, and 99.6 percent, respectively); there were few false-positive or false-negative findings (0.4 and 0.3 percent, respectively).

"Standardized surveillance successfully uncovers new asymptomatic tumors in children and young adults across a broad range of CPSs," the authors write.

One author disclosed ties to Alexion.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-22 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords